HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 44 filers reported holding HOOKIPA PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $98,677 | -33.7% | 160,190 | -5.3% | 0.00% | – |
Q2 2023 | $148,873 | +41.6% | 169,174 | +18.5% | 0.00% | – |
Q1 2023 | $105,106 | -54.6% | 142,807 | -50.0% | 0.00% | – |
Q4 2022 | $231,348 | -1.1% | 285,614 | +63.5% | 0.00% | – |
Q3 2022 | $234,000 | -17.6% | 174,690 | +0.3% | 0.00% | – |
Q2 2022 | $284,000 | -70.9% | 174,125 | -59.4% | 0.00% | – |
Q1 2022 | $977,000 | +26.6% | 428,534 | +29.3% | 0.00% | – |
Q4 2021 | $772,000 | -63.7% | 331,477 | -8.1% | 0.00% | – |
Q3 2021 | $2,125,000 | -28.8% | 360,771 | +10.7% | 0.00% | – |
Q2 2021 | $2,986,000 | +12.8% | 326,012 | +65.7% | 0.00% | – |
Q1 2021 | $2,647,000 | +19.4% | 196,798 | -1.5% | 0.00% | – |
Q4 2020 | $2,216,000 | +16.5% | 199,827 | -0.5% | 0.00% | – |
Q3 2020 | $1,902,000 | -15.1% | 200,807 | +4.2% | 0.00% | – |
Q2 2020 | $2,239,000 | +129.9% | 192,722 | +63.3% | 0.00% | – |
Q1 2020 | $974,000 | -14.0% | 118,011 | +27.3% | 0.00% | – |
Q4 2019 | $1,133,000 | +522.5% | 92,668 | +282.9% | 0.00% | – |
Q3 2019 | $182,000 | +35.8% | 24,203 | -1.4% | 0.00% | – |
Q2 2019 | $134,000 | – | 24,536 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 5,517,385 | $3,398,709 | 3.53% |
Artal Group S.A. | 5,666,410 | $3,491 | 0.15% |
EcoR1 Capital, LLC | 4,595,024 | $2,830,535 | 0.10% |
Ikarian Capital, LLC | 530,776 | $326,958 | 0.04% |
ARMISTICE CAPITAL, LLC | 3,712,000 | $2,286,592 | 0.04% |
Redmile Group, LLC | 1,063,769 | $655,282 | 0.03% |
Baker Brothers Advisors | 8,065,398 | $4,968,285 | 0.03% |
XTX Topco Ltd | 162,744 | $100,250 | 0.02% |
Alyeska Investment Group, L.P. | 3,109,436 | $1,915,413 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 117,695 | $72,500 | 0.00% |